H. Nishiyama

发表

Redistribution of resistance and sensitivity to platinum during the observation period following treatment of epithelial ovarian cancer.

K. Fujimori, N. Yaegashi, H. Kurachi, 2014, Molecular and clinical oncology.

Phase II Clinical Study of the Combination Chemotherapy Regimen of Irinotecan Plus Oral Etoposide for the Treatment of Recurrent Ovarian Cancer (Tohoku Gynecologic Cancer Unit 101 Group Study)

N. Yaegashi, H. Kurachi, H. Mizunuma, 2010, International Journal of Gynecologic Cancer.

Production of IL1-beta by ovarian cancer cells induces mesothelial cell beta1-integrin expression facilitating peritoneal dissemination

T. Sugino, S. Goodison, K. Fujimori, 2012, Journal of Ovarian Research.

Paclitaxel–carboplatin for advanced or recurrent carcinosarcoma of the uterus: the Japan Uterine Sarcoma Group and Tohoku Gynecologic Cancer Unit Study

J. Kigawa, M. Shimada, N. Yaegashi, 2014, International Journal of Clinical Oncology.

Elevated serum levels of vascular endothelial growth factor is effective as a marker for malnutrition and inflammation in patients with ovarian cancer.

K. Fujimori, S. Takenoshita, S. Soeda, 2013, Biomedical reports.

A phase I study of irinotecan and pegylated liposomal doxorubicin in recurrent ovarian cancer (Tohoku Gynecologic Cancer Unit 104 study)

K. Fujimori, N. Yaegashi, H. Mizunuma, 2014, Cancer Chemotherapy and Pharmacology.

Paclitaxel and Carboplatin in Patients With Completely or Optimally Resected Carcinosarcoma of the Uterus: A Phase II Trial by the Japanese Uterine Sarcoma Group and the Tohoku Gynecologic Cancer Unit

M. Shimada, H. Katabuchi, N. Yaegashi, 2015, International Journal of Gynecologic Cancer.

Clinical and reproductive outcomes of fertility-sparing surgery in stage I epithelial ovarian cancer

T. Baba, K. Fujimori, N. Yaegashi, 2019, Molecular and clinical oncology.

Evaluation of postoperative chemotherapy in patients with uterine carcinosarcoma: a retrospective survey of the Tohoku Gynecologic Cancer Unit

K. Fujimori, N. Yaegashi, T. Ohta, 2015, International Journal of Clinical Oncology.

Serum levels of rapid turnover proteins are decreased and related to systemic inflammation in patients with ovarian cancer

K. Fujimori, S. Takenoshita, S. Soeda, 2013, Oncology letters.

DYSGERMINOMA WITH SYNCYTIOTROPHOBLASTIC GIANT CELLS ARISING FROM 46,XX PURE GONADAL DYSGENESIS

K. Yanagida, H. Nishiyama, A. Sato, 1998, Obstetrics and gynecology.

Yolk sac tumor of the ovary: a retrospective multicenter study of 33 Japanese women by Tohoku Gynecologic Cancer Unit (TGCU).

K. Fujimori, N. Yaegashi, H. Kurachi, 2013, The Tohoku journal of experimental medicine.

Tumor-associated macrophages correlate with vascular space invasion and myometrial invasion in endometrial carcinoma.

H. Hojo, N. Nakamura, S. Soeda, 2008, Gynecologic oncology.

MCP-1 promotes invasion and adhesion of human ovarian cancer cells.

K. Fujimori, H. Hojo, K. Tasaki, 2013, Anticancer research.

Uterine arteriovenous malformation formed in a large uterine cervical myoma.

K. Fujimori, S. Soeda, Takafumi Watanabe, 2012, The Tohoku journal of experimental medicine.

Prognostic Significance of Aberrant Claudin-6 Expression in Endometrial Cancer

Yuta Endo, K. Fujimori, H. Chiba, 2020, Cancers.

Sclerosing stromal tumor of the ovary treated with 2-incision total laparoscopic cystectomy

K. Fujimori, S. Soeda, K. Kanno, 2015, International journal of surgery case reports.

The measurement of stiffness of uterine smooth muscle tumor by elastography

K. Fujimori, S. Soeda, Takafumi Watanabe, 2014, SpringerPlus.

Surgical management of recurrent gynecological cancer: Complete resection is the key to longer survival

K. Fujimori, S. Soeda, A. Kenjo, 2019 .

Efficacy of neoadjuvant chemotherapy followed by radical hysterectomy in locally advanced non-squamous carcinoma of the uterine cervix: a retrospective multicenter study of Tohoku Gynecologic Cancer Unit.

N. Yaegashi, Y. Yokoyama, T. Sugiyama, 2012, European journal of gynaecological oncology.

Association between growth factor heregulin1α and receptors in growth of ovarian cancer cell line with high potentiality of peritoneal dissemination.

K. Fujimori, S. Soeda, Takafumi Watanabe, 2012, Fukushima journal of medical science.

Aberrant claudin-6–adhesion signal promotes endometrial cancer progression via estrogen receptor α

Yuta Endo, K. Fujimori, H. Chiba, 2020, bioRxiv.

Outcomes of abdominal radical trachelectomy: results of a multicenter prospective cohort study in a Tohoku Gynecologic Cancer Unit

N. Yaegashi, T. Ohta, S. Nagase, 2014, International Journal of Clinical Oncology.

Investigation of the clinicopathological features of squamous cell carcinoma of the vulva: a retrospective survey of the Tohoku Gynecologic Cancer Unit

K. Fujimori, N. Yaegashi, K. Jingu, 2015, International Journal of Clinical Oncology.

A phase II study of irinotecan and pegylated liposomal doxorubicin in platinum-resistant recurrent ovarian cancer (Tohoku Gynecologic Cancer Unit 104 study)

N. Yaegashi, T. Ohta, S. Nagase, 2017, Cancer Chemotherapy and Pharmacology.

Addendum: Manabu, K., et al. Prognostic Significance of Aberrant Claudin-6 Expression in Endometrial Cancer. Cancers 2020, 12, 2748

Yuta Endo, K. Fujimori, H. Chiba, 2021, Cancers.

Title Association between growth factor heregulin -1α and receptors in growth of ovarian cancer cell line with high potentiality of peritoneal dissemination

K. Fujimori, Keiya, S. Soeda, 2022 .

Hepatoma associated with anabolic steroid therapy.

L. Holder, B. Lampkin, H. Nishiyama, 1975, The American journal of roentgenology, radium therapy, and nuclear medicine.